India Market Stares At Five-Year Growth Cutback But Buoyant

IQVIA’s general manager (South Asia), Amit Mookim, outlines the reasons for scaling down the five-year outlook for the Indian pharmaceutical market, including a near halving of the prognosis for 2017.